Aimm Therapeutics

Develops therapeutic human monoclonal antibodies for infectious diseases and cancer

placeAmsterdam, North Holland, Netherlands calendar_todayFounded 2004 groups9 employees language aimmtherapeutics.com

Innovation

19 patent families (14 granted) — focus: Chemistry & metallurgy, Physics & computing, Operations & transport; filing pace slowing. Cited 3,596 times.

YearFilings
20126
20135
20144
201512
201610
201712
20189
20197
20207
20215
20223
20233

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon